Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:1240-1247

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bani, D.
Right arrow Articles by Masini, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bani, D.
Right arrow Articles by Masini, E.

(Hypertension. 1998;31:1240-1247.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Relaxin Activates the L-Arginine–Nitric Oxide Pathway in Vascular Smooth Muscle Cells in Culture

Daniele Bani; Paola Failli; Maria Grazia Bello; Christoph Thiemermann; Tatiana Bani Sacchi; Mario Bigazzi; ; Emanuela Masini

From the Departments of Human Anatomy and Histology (D.B., T.B.S.) and of Preclinical and Clinical Pharmacology (P.F., M.G.B., E.M.), University of Florence; the Prosperius Institute (M.B.), Florence, Italy; and the William Harvey Research Institute, London, UK (C.T.).

Correspondence to Prof Tatiana Bani Sacchi, Dipartimento di Anatomia Umana e Istologia, Sezione di Istologia, Viale G. Pieraccini 6, I-50139 Firenze, Italy. E-mail histology{at}cesit1.unifi.it

Abstract—The peptide hormone relaxin (RLX) has been shown to elicit a powerful vasodilatory response in several target organs. This response is mediated by the stimulation of intrinsic nitric oxide (NO) generation. The present study was designed to clarify whether RLX directly promotes the relaxation of vascular smooth muscle cells through stimulation of NO generation. Vascular smooth muscle cells from bovine aortas were incubated with RLX at concentrations ranging from 1 nmol/L to 1 µmol/L. The expression and activity of NO synthase, production of NO, and the intracellular levels of cGMP and Ca2+ were determined. The cell morphology and signal transduction mechanisms of these bovine aortic smooth muscle cells in response to RLX were also studied. RLX stimulated the expression of immunoreactive inducible NO synthase and increased significantly and in a concentration-related fashion inducible NO synthase activity, NO generation, and intracellular cGMP levels. Concurrently, RLX significantly decreased cytosolic Ca2+ concentrations and caused changes in cell shape and the actin cytoskeleton that were consistent with cell relaxation. The signal transduction mechanisms leading to the enhanced expression of inducible NO synthase protein and activity caused by RLX involve the activation of tyrosine kinase, phosphatidylcholine–phospholipase C, and the transcription factor nuclear factor-{kappa}B, similar to bacterial endotoxins and proinflammatory cytokines. This study suggests that RLX is an endogenous agent capable of regulating vascular tone by activation of the L-arginine–NO pathway in vascular smooth muscle cells.


Key Words: muscle, smooth, vascular • relaxin • nitric oxide




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox
Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism
J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Nguyen and C. W. Dessauer
Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production
Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Baccari, D. Bani, M. Bigazzi, and F. Calamai
Influence of Relaxin on the Neurally Induced Relaxant Responses of the Mouse Gastric Fundus
Biol Reprod, October 1, 2004; 71(4): 1325 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Quattrone, L. Chiappini, G. Scapagnini, B. Bigazzi, and D. Bani
Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture
Mol. Hum. Reprod., May 1, 2004; 10(5): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Masini, S. Nistri, A. Vannacci, T. B. Sacchi, A. Novelli, and D. Bani
Relaxin Inhibits the Activation of Human Neutrophils: Involvement of the Nitric Oxide Pathway
Endocrinology, March 1, 2004; 145(3): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Baccari, S. Nistri, S. Quattrone, M. Bigazzi, T. Bani Sacchi, F. Calamai, and D. Bani
Depression by Relaxin of Neurally Induced Contractile Responses in the Mouse Gastric Fundus
Biol Reprod, January 1, 2004; 70(1): 222 - 228.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Nguyen, L. Yang, B. M. Sanborn, and C. W. Dessauer
Phosphoinositide 3-Kinase Activity Is Required for Biphasic Stimulation of Cyclic Adenosine 3',5'-Monophosphate by Relaxin
Mol. Endocrinol., June 1, 2003; 17(6): 1075 - 1084.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Fisher, M. MacLean, I. Morecroft, A. Seed, F. Johnston, C. Hillier, and J. McMurray
Is the Pregnancy Hormone Relaxin Also a Vasodilator Peptide Secreted by the Heart?
Circulation, July 16, 2002; 106(3): 292 - 295.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Bani, M. Caterina Baccari, S. Quattrone, S. Nistri, F. Calamai, M. Bigazzi, and T. Bani Sacchi
Relaxin Depresses Small Bowel Motility Through a Nitric Oxide-Mediated Mechanism. Studies in Mice
Biol Reprod, March 1, 2002; 66(3): 778 - 784.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Kristiansson and J.X. Wang
Reproductive hormones and blood pressure during pregnancy
Hum. Reprod., January 1, 2001; 16(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. D. Sherwood, L. M. Olson, S. Zhao, and H. R. Little
Inhibition of Nitric Oxide Synthase Activity Diminishes the Acute Effects of Relaxin on Growth, But Not Softening, of the Cervix in the Rat
Endocrinology, July 1, 2000; 141(7): 2458 - 2464.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Bani, M. C. Baccari, S. Nistri, F. Calamai, M. Bigazzi, and T. B. Sacchi
Relaxin Up-Regulates the Nitric Oxide Biosynthetic Pathway in the Mouse Uterus: Involvement in the Inhibition of Myometrial Contractility
Endocrinology, October 1, 1999; 140(10): 4434 - 4441.
[Abstract] [Full Text]